Detalhe da pesquisa
1.
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation.
Ann Hematol
; 2024 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38900303
2.
Eltrombopag improves platelet engraftment after haploidentical bone marrow transplantation: Results of a Phase II study.
Am J Hematol
; 99(4): 562-569, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38314663
3.
Effective T-cell replete haploidentical stem cell transplantation for pediatric patients with high-risk hematologic disorders.
Eur J Haematol
; 110(3): 305-312, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451282
4.
Improved outcomes of high-risk relapsed Hodgkin lymphoma patients after high-dose chemotherapy: a 15-year analysis.
Haematologica
; 107(4): 899-908, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33951890
5.
Haploidentical Hematopoietic Stem Cell Transplantation in Thalassemia.
Hemoglobin
; 46(1): 2-6, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920292
6.
Fractionated busulfan myeloablative conditioning improves survival in older patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer
; 127(10): 1598-1605, 2021 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471943
7.
Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
Acta Haematol
; 144(1): 74-81, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32604096
8.
Optimizing the Conditioning Regimen for Hematopoietic Cell Transplant in Myelofibrosis: Long-Term Results of a Prospective Phase II Clinical Trial.
Biol Blood Marrow Transplant
; 26(8): 1439-1445, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32438043
9.
Hematopoietic Stem Cell Transplantation for Severe Thalassemia Patients from Haploidentical Donors Using a Novel Conditioning Regimen.
Biol Blood Marrow Transplant
; 26(6): 1106-1112, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31931116
10.
Effect of nonpermissive HLA-DPB1 mismatches after unrelated allogeneic transplantation with in vivo T-cell depletion.
Blood
; 131(11): 1248-1257, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29386198
11.
Targeted-dose of busulfan: Higher risk of sinusoidal obstructive syndrome observed with systemic exposure dose above 5000 µMol⸱min. A historically controlled clinical trial.
Hematol Oncol
; 38(5): 773-781, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32779746
12.
Development and validation of a risk assessment tool for BKPyV Replication in allogeneic stem cell transplant recipients.
Transpl Infect Dis
; 22(5): e13395, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32602954
13.
Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.
Blood
; 129(10): 1389-1393, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28049637
14.
Early Post-Transplant Minimal Residual Disease Assessment Improves Risk Stratification in Acute Myeloid Leukemia.
Biol Blood Marrow Transplant
; 24(7): 1514-1520, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448058
15.
Allogeneic Stem Cell Transplantation for Advanced Myelodysplastic Syndrome: Comparison of Outcomes between CD34+ Selected and Unmodified Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 24(5): 1079-1087, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29325829
16.
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan with Autologous Stem Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 24(8): 1602-1609, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29501779
17.
Clofarabine Plus Busulfan is an Effective Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Lymphoblastic Leukemia: Long-Term Study Results.
Biol Blood Marrow Transplant
; 23(2): 285-292, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27816651
18.
Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation.
Blood
; 125(19): 2885-92, 2015 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25778529
19.
Pre-transplantation minimal residual disease with cytogenetic and molecular diagnostic features improves risk stratification in acute myeloid leukemia.
Haematologica
; 102(1): 110-117, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540139
20.
A myeloablative fractionated busulfan conditioning regimen with post-transplant cyclophosphamide in HLA-matched and haploidentical transplantation: results of a phase II study.
Haematologica
; 107(10): 2496-2500, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35770531